Royalty Pharma plcRPRXNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank20
3Y CAGR+150.1%
5Y CAGR-10.1%
Year-over-Year Change
Return on equity
3Y CAGR
+150.1%/yr
vs -60.3%/yr prior
5Y CAGR
-10.1%/yr
Recent acceleration
Acceleration
+210.4pp
Accelerating
Percentile
P20
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 11.90% | -3.7% |
| 2024 | 12.37% | -28.9% |
| 2023 | 17.39% | +2184.8% |
| 2022 | 0.76% | -92.9% |
| 2021 | 10.73% | -47.0% |
| 2020 | 20.23% | -47.4% |
| 2019 | 38.47% | +25.3% |
| 2018 | 30.70% | +13.2% |
| 2017 | 27.13% | +113.1% |
| 2016 | 12.73% | - |